editor@hikmahplus.com ISSN: 2XXX-XXXX (Online)
Review Article Pharmacy

Minireview on CB1 Receptor Allosteric Modulation

Authors: Brenda Chia Ming Yee, Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom, Selangor, Malaysia Phang Yi Ying, Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom, Selangor, Malaysia Kong Chek Kouk*, Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom, Selangor, Malaysia ghaljabal@gmail.com *Corresponding author
Volume: 1 | Issue: 1 | Pages: 19-28 | Published: Feb 01, 2026
Email
0 0
Article Metrics

Track mentions across social media, news, and blogs.

View details
Quick Access
QR Code

Scan with your phone to read this article on mobile

Abstract

The endocannabinoid system (ECS) constitutes a multifaceted neuromodulatory network orchestrating a spectrum of physiological processes through the interplay of endogenous ligands, metabolic enzymes, and cannabinoid receptors (CB1R and CB2R). Among these, CB1R—an abundantly expressed G protein-coupled receptor (GPCR)—exerts pivotal influence on neurological, metabolic, and nociceptive functions. Therapeutic exploitation of CB1R, however, has historically been constrained by the neuropsychiatric liabilities associated with orthosteric ligands. In this context, allosteric modulation, targeting receptor sites topographically distinct from the orthosteric pocket, has emerged as a strategy capable of conferring both subtype selectivity and enhanced safety. Herein, we synthesize recent progress in the discovery, structural characterization, and pharmacological evaluation of CB1R allosteric modulators, emphasizing mechanistic heterogeneity, therapeutic implications, and the evolving paradigms for rational drug design.

Keywords:
CB1 receptor Allosteric modulation Endocannabinoid system Positive allosteric modulators Negative allosteric modulators GPCR

Full Article

Click "View PDF" to read the article inline, or download for offline reading.

Article History

Submitted: Dec 20, 2025
Accepted: Jan 15, 2026
Published: Feb 01, 2026

Rights & Permissions

No References Available

References for this article have not been provided.

Author Information

Brenda Chia Ming Yee

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom, Selangor, Malaysia

Phang Yi Ying

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom, Selangor, Malaysia

Kong Chek Kouk Corresponding

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom, Selangor, Malaysia

Cited By

Loading...

Checking CrossRef for citations...

Citation data provided by CrossRef. Search on CrossRef →

Article Versions

Current Version of Record - Published Feb 01, 2026
Last updated: Apr 08, 2026

No corrections or errata have been issued for this article.

How to Cite

Ming Yee, B., Yi Ying, P., Chek Kouk, K. (2026). Minireview on CB1 Receptor Allosteric Modulation. BiomedicaSphere, 1(1), 19-28. https://doi.org/10.59324/bmsj.2026.1(1).03